Importantly, the aerosolized delivery of a novel TLR4 small molecule inhibitor was sufficient to reverse this inflammatory cascade and prevent the lung injury normally triggered by NEC in this model. This evidence concerns the gene TLR4 and necrotizing enterocolitis.